United Kingdom· GB-APID-3638211000001100
Neo-Naclex-K modified-release tablets
A bendroflumethiazide and potassium product containing bendroflumethiazide + potassium, registered in United Kingdom by Mercury Pharma Group Ltd. The same ATC class is registered in 5 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bendroflumethiazide and potassium is registered in 5 of 19 countries.
Countries holding a registration under ATC C03AB01 (bendroflumethiazide and potassium), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 2 of them publish a price we can compare per daily dose
Bendroflumethiazide and potassium · ATC C03AB01
5 / 19 countries
- Denmark
- Icelandprice
- Ireland
- Norwayprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bendroflumethiazide + Potassium
- Manufacturer
- Mercury Pharma Group Ltd
- Country
- United Kingdom (GB)
- ATC code
- C03AB01
- ATC class
- Bendroflumethiazide and potassium
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5021691910008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bendroflumethiazide and potassium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayBendrozaTeva B.V.
- IrelandCentyl K 2.5 mg/573 mg modified-release tabletsKaro Pharma AB
- IcelandCentyl með kaliumkloridKaro Pharma AB*
- SwedenCentyl K 2,5 mg/573 mg Filmdragerad tablettKaro Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Denmark · Bendroza, Centyl Med Kaliumklorid
- Ireland · Centyl K, Low Centyl K
- Iceland · Centyl Med Kaliumklorid, Centyl Mite Med Kaliumklorid
- Norway · Centyl Med Kaliumklorid, Centyl Mite Med Kaliumklorid
- Sweden · Centyl K, Centyl K Mite
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cac70e0d-5e27-4e92-ab23-81d74698a6c7 GET /v1/drugs/cac70e0d-5e27-4e92-ab23-81d74698a6c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3638211000001100",
"desc": "Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd)",
"form": "Modified-release tablet",
"vpid": "35910111000001106",
"source": "dmd",
"vtm_id": "774766007",
"strength": "630 mg",
"substance": "Bendroflumethiazide + Potassium",
"ingredient": "Potassium chloride",
"supplier_code": "151601000001102"
}See everything about bendroflumethiazide and potassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.